ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologi - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
natrijev klorid braun 9 mg/ml raztopina za infundiranje
b. braun melsungen ag - natrijev klorid - raztopina za infundiranje - natrijev klorid 9 mg / 1 ml - elektroliti
natrijev klorid braun 9 mg/ml raztopina za infundiranje
b. braun melsungen ag - natrijev klorid - raztopina za infundiranje - natrijev klorid 9 mg / 1 ml - elektroliti
glukoza braun 50 mg/ml raztopina za infundiranje
b. braun melsungen ag - glukoza, brezvodna - raztopina za infundiranje - glukoza, brezvodna 50 g / 1000 mlglukoza monohidrat - ogljikovi hidrati
natrijev klorid braun 9 mg/ml raztopina za infundiranje
b. braun melsungen ag - natrijev klorid - raztopina za infundiranje - natrijev klorid 9 mg / 1 ml - elektroliti
drontal cat
bayer -
parofor crypto teleta
huvepharma nv uitbreidingstraat 80 2600 antwerpen belgija proizvajalec odgovoren za sproščanje serij: biovet jsc petar rakov street 39 4550 peštera bolgarija 2 -